Deutsche Lufthansa has to do more to allay European Union concerns about its takeover of most of Air Berlin after offering concessions that won’t fully appease regulators, according to two people familiar with the process.
Lufthansa would need to improve upon its offer to cede landing rights of Air Berlin’s Niki arm in order to win approval for the deal, according to the people, who spoke on condition of anonymity.
While Lufthansa Chief Executive Officer Carsten Spohr has said the carrier would “practically buy Niki without slots,” the offer submitted to the European Commission shows the company will hold on to many of Niki’s slots in Germany, including at congested airports such as Munich and Berlin Tegel, the people said.
The concessions were sent to rivals and customers for feedback on Wednesday with a response deadline of December 11.
EU Competition Commissioner Margrethe Vestager has flagged “very serious overlaps” and “a risk of a very strong limitation of competition on quite a number of routes” that might lead to worse service and higher prices for flights in Germany. Regulators have until December 21 to clear the acquisition with concessions or open an extended investigation. Lufthansa is keen for a quick decision to keep costs in check or it may walk away from the deal.
Full Content: Financial Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas